Skip to content
sellWeak

Thierry Chauche sold $7,033 of SGMT

Chief Financial Officer at Sagimet Biosciences Inc.. 1,312 shares at an average of $5.36, traded Feb 10, 2026, filed Feb 12, 2026.

Warning score
22
Value
$7,033
1,312 shares
Holdings after
15,688
-8% from before
From 52-week low
+197%
low $1.90, close $5.64
From 52-week high
-45%
high $10.24, as of Feb 10, 2026

Score components

  • Role
    CFO
    +22
  • Trade size
    $7k at market
    0
  • Share of holdings sold
    Sold 7.7% of holdings
    0
  • Cluster
    No other insider selling within 14 days
    0

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

SGMTOct 9, 2026 · close 8.93
Since filing Feb 12, 2026: +73.4%SPY +15.2% · excess +58.2%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001104659-26-014277, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Feb 10, 2026SOpen-market sale
Series A Common Stock
-1,312$5.36$7,03315,688Feb 12, 2026

Related signals

Other insiders at Sagimet Biosciences Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
24Weak
SGMTsell10b5-1
Sagimet Biosciences Inc.
George Kemble
Executive Chairman
$290k
37,688 shares
-32%
59Moderate
SGMTsell 3
Sagimet Biosciences Inc.
David Happel
President & CEO
$598k
65,478 shares
-9%
38Weak
SGMTsell 3
Sagimet Biosciences Inc.
Eduardo Bruno Martins
Chief Medical Officer
$76k
8,277 shares
-7%
40Moderate
SGMTsell 3
Sagimet Biosciences Inc.
Elizabeth Rozek
General Counsel and CCO
$98k
10,780 shares
-6%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Thierry Chauche sold $7,033 of SGMT | InsiderTell